The AI in Business Podcast

In this enlightening discussion, Miranda Jones, SVP Data & AI Strategy Leader at Emprise Bank, dives into the vital role of transparency in AI deployment within financial services. She emphasizes that embedding explainability improves compliance workflows and builds trust. Miranda highlights the need for collaboration between data scientists and frontline employees, arguing that defining meaningful KPIs is crucial for success. The conversation also addresses the balance between regulatory requirements and enhancing customer experiences, showcasing the importance of co-designed solutions.

Mark Fredman, Chief Strategy Officer at CCC Intelligent Solutions, dives into how AI is revolutionizing the insurance supply chain. He explains the impressive use of computer vision for predicting total losses and generative AI for document summarization. He advocates for insurers to move from siloed operations to a collaborative 'insurance economy.' Mark shares strategies for successful AI adoption, emphasizing quick wins and integrating AI alongside human expertise to enhance efficiency and customer experience in insurance workflows.

Brad Kennedy, Senior Director of Business Solutions Strategy at Orlando Health, discusses the transformative potential of AI in healthcare. He emphasizes the balance of improving patient experience and easing clinician workloads without compromising physician judgment. Kennedy shares insights from the shift to value-based care and the crucial role of patient feedback in healthcare quality. He also addresses the ongoing evolution sparked by the COVID-19 pandemic and the future of AI in clinical decision support, underscoring the importance of trust and collaboration among stakeholders.

Raheel Retiwalla, Chief Strategy Officer at Productive Edge, dives into the transformative power of Agentic AI in healthcare. He discusses how AI shifts care management from reactive to proactive, using real-time data for better patient outcomes. Raheel shares practical use cases, such as AI monitoring for care disruptions and identifying behavioral health risks through appointment patterns. He emphasizes the potential of AI to optimize resource allocation in chronic disease management, stressing its importance for healthcare leaders in improving workflows without additional staffing.

Emily Nguyen, Head of Industrials at Palantir Technologies, shares her expertise on scaling AI in manufacturing, drawing insights from Project Warp Speed. She discusses the importance of mission focus and first-principles thinking for successful AI adoption. Emily highlights innovative applications like visual inspection and predictive maintenance. She emphasizes starting small with AI projects and integrating them into existing systems. The conversation also touches on enhancing supply chain connectivity and preserving tribal knowledge for future industrial collaboration.

Kevin Kiley, President of Airia, shares his expertise in making enterprise AI secure and effective. He discusses the rise of Agentic AI, which allows for autonomous operations and reshapes workflows, especially in finance. Kiley emphasizes the importance of human oversight in AI integration to ensure compliance. He outlines a roadmap for organizations, advocating for starting with smaller projects before scaling up. Kiley also highlights the need for real-time safeguards as AI's capabilities and associated risks evolve.

Dr. Ankur Sharma, Head of Medical Affairs for Medical Devices and Digital Radiology at Bayer, dives into the intricate world of AI in healthcare. He highlights the significant hurdles like data privacy and regulatory uncertainty that healthcare institutions face in adopting AI tools. The discussion also covers the vital distinction between regulated predictive models and unregulated generative tools, and how AI can connect clinical research with real-world patient care. Sharma emphasizes the need for new reimbursement strategies to facilitate the growth of digital health innovations.

David Glick, Senior Vice President of Enterprise Business Services at Walmart, shares insights on scaling AI in one of the world’s largest retailers. He discusses the innovative use of 'nano agents' to tackle specific business challenges and the importance of agile development processes. Glick explains how direct collaboration between engineers and domain experts enhances efficiency while navigating organizational hurdles. He also addresses the strategic balance of building versus buying technology solutions in a rapidly evolving landscape.

Annabel Romero, a Specialist Leader at Deloitte and a trained structural biologist, dives into the world of AI in life sciences. She elaborates on how AI, especially tools like AlphaFold, mimics scientific thinking to accelerate drug discovery and protein modeling. The discussion highlights the growing role of AI in understanding allergens and enhancing agricultural innovation. Annabel also emphasizes the balance of human insight in interpreting AI advancements, showcasing the ethical responsibilities tied to these powerful technologies.

Yunke Xiang, the Global Head of Data Science for Manufacturing at Sanofi, dives into the hurdles facing AI adoption in life sciences. He highlights how fragmented data sources and outdated infrastructure impede progress. Yunke discusses the balance of building versus buying AI solutions and the pivotal role of leadership in nurturing data science. He emphasizes the need for strong governance and collaboration to successfully implement AI. The conversation offers a rare glimpse into the complexities of transforming pharmaceutical manufacturing with cutting-edge technologies.